Kirkland Biotech's Hepatitis D Drug Reaches FDA Review

A Kirkland biotechnology company just hit a major milestone that could bring hope to thousands living with a rare liver disease.

The FDA has accepted EIT Pharma's new drug application for treating chronic hepatitis D.